Hillerød, Denmark

Helle Weibel

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Hiller.o slashed.d, DK (1998 - 1999)
  • Hilleroed, DK (1999)
  • Hillerod, DK (2004)
  • Hillerød, DK (2008)

Company Filing History:


Years Active: 1998-2008

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Helle Weibel: Innovator in Pharmaceutical Composition

Introduction

Helle Weibel is a distinguished inventor based in Hillerød, Denmark. She has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. Her work focuses on developing stable pharmaceutical compositions that have the potential to improve patient outcomes.

Latest Patents

Among her latest patents, Helle Weibel has developed a pharmaceutical composition and the process for its preparation. This invention provides a new stable pharmaceutical composition containing 5-[[4-[3-Methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenyl-methyl]thiadiazolidine-2,4-dione as the active ingredient. Another notable patent also involves a similar composition, emphasizing her innovative approach to pharmaceutical formulations.

Career Highlights

Throughout her career, Helle Weibel has worked with prominent companies in the pharmaceutical industry. Notably, she has been associated with Novo Nordisk A/S and Dr. Reddy's Laboratories, Incorporated. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking advancements in medicine.

Collaborations

Helle has collaborated with esteemed colleagues, including Thyge Borup Hjorth and Peter Bonne Eriksen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Helle Weibel's contributions to pharmaceutical innovation are noteworthy, and her patents reflect her commitment to advancing healthcare solutions. Her work continues to inspire future generations of inventors in the pharmaceutical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…